About RH Medical Urgent Care
Clinical Trials at RH Medical Urgent Care
During the past decade, RH Medical Urgent Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at RH Medical Urgent Care
According to Clinical.Site data, the most researched conditions in "RH Medical Urgent Care" are
"COVID-19" (1 trials), "Enterovirus" (1 trials) and "Rhinovirus" (1 trials). Many other conditions were trialed in "RH Medical Urgent Care" in a lesser frequency.
Clinical Trials Intervention Types at RH Medical Urgent Care
Most popular intervention types in "RH Medical Urgent Care" are "Dietary Supplement" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nitazoxanide" (2 trials), "Placebo" (2 trials) and "Vitamin Super B-Complex" (2 trials). Other intervention names were less common.
Clinical Trials Genders at RH Medical Urgent Care
The vast majority of trials in "RH Medical Urgent Care" are
2 trials for "All" genders.
Clinical Trials Status at RH Medical Urgent Care
Currently, there are NaN active trials in "RH Medical Urgent Care".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in RH Medical Urgent Care,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in RH Medical Urgent Care, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".